Núñez Julio, Núñez Eduardo, Robles Rocío, Bodí Vicent, Sanchis Juan, Carratalá Arturo, Aparici Manuel, Llàcer Angel
Servicio de Cardiología, Hospital Clínic i Universitari, Universidad de Valencia, Valencia, Spapin.
Rev Esp Cardiol. 2008 Dec;61(12):1332-7. doi: 10.1016/s1885-5857(09)60062-1.
The prognostic value of brain natriuretic peptide (BNP) measurement in patients with acute heart failure is not well understood. The aim of this study was to investigate the relationship between the BNP level and mortality and readmission for acute heart failure. We studied 569 consecutive patients who were admitted with a diagnosis of acute heart failure. The BNP level was measured after the patient became clinically stable. The relationship between the BNP level and mortality was assessed by Cox regression analysis, and the relationship with readmission, by competing risks regression analysis. During a median follow-up period of 9 (range, 3-18) months, 156 deaths (27.4%) and 140 readmissions (24.6%) occurred. Multivariate analysis demonstrated a positive linear association between the risk of death and the BNP quintile. In contrast, the BNP level did not predict readmission for acute heart failure, mainly because of the effect of death as a competing outcome.
脑钠肽(BNP)检测对急性心力衰竭患者的预后价值尚未完全明确。本研究旨在探讨BNP水平与急性心力衰竭患者死亡率及再入院率之间的关系。我们对569例连续诊断为急性心力衰竭的患者进行了研究。患者临床症状稳定后检测BNP水平。通过Cox回归分析评估BNP水平与死亡率之间的关系,通过竞争风险回归分析评估其与再入院率之间的关系。在中位随访期9(范围3 - 18)个月内,发生了156例死亡(27.4%)和140例再入院(24.6%)。多变量分析显示死亡风险与BNP五分位数之间呈正线性关联。相比之下,BNP水平不能预测急性心力衰竭患者的再入院率,主要原因是死亡作为竞争结局产生的影响。